Gene S
Latest round
- Seed
Last raised
- Oct 2023
Total raised
- $0.6M
Investors
- 2
About Gene S
Based in Nedlands, Australia, and founded in 2020, Gene S Pty Ltd. is a biotechnology company specializing in genetic solutions to enable personalized prescription medication through pharmacogenomics. The company was co-founded by Svetlana Baltic (CEO) and Suzanna Lindsey-Temple (CMO). In November 2023, Gene S Pty Ltd. The company provides a selection of products and services centered around personalized prescription medication using pharmacogenomics. Their offerings encompass genetic testing, educational resources, and partnering with healthcare providers such as doctors, pharmacists, and other medical professionals to integrate services into patient care.
Who invested in Gene S
2 investors across 1 round
See all investors in Gene S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 26, 2023
Amount
$0.6M
Investors
Questions about Gene S
Who invested in Gene S?
Gene S has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gene S raised?
Gene S has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gene S last raise money?
Gene S's most recent round on record is a Seed, in Oct 2023.
What does Gene S do?
Based in Nedlands, Australia, and founded in 2020, Gene S Pty Ltd.
Where is Gene S headquartered?
Gene S is headquartered in Nedlands, Australia.
Which VCs invest in companies like Gene S?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Gene S's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Gene S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.